Nanocomposites for neurodegenerative diseases: Hydrogel-nanoparticle combinations for a challenging drug delivery

Carmen Giordano, Diego Albani, Antonio Gloria, Marta Tunesi, Serena Rodilossi, Teresa Russo, Gianluigi Forloni, Luigi Ambrosio, Alberto Cigada

Research output: Contribution to journalArticle

Abstract

Neurodegenerative disorders are expected to strike social and health care systems of developed countries heavily in the coming decades. Alzheimer's and Parkinson's diseases (AD/PD) are the most prevalent neurodegenerative pathologies, and currently their available therapy is only symptomatic. However, innovative potential drugs are actively under development, though their efficacy is sometimes limited by poor brain bioavailability and/or sustained peripheral degradation. To partly overcome these constraints, the development of drug delivery devices made by biocompatible and easily administrable materials might be a great adjuvant. In particular, materials science can provide a powerful tool to design hydrogels and nanoparticles as basic components of more complex nanocomposites that might ameliorate drug or cell delivery in AD/PD. This kind of approach is particularly promising for intranasal delivery, which might increase brain targeting of neuroprotective molecules or proteins. Here we review these issues, with a focus on nanoparticles as nanocomponents able to carry and tune drug release in the central nervous system, without ignoring warnings concerning their potential toxicity.

Original languageEnglish
Pages (from-to)1115-1127
Number of pages13
JournalInternational Journal of Artificial Organs
Volume34
Issue number12
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Neurodegenerative diseases
Nanocomposites
Hydrogel
Drug delivery
Hydrogels
Neurodegenerative Diseases
Nanoparticles
Brain
Parkinson Disease
Neurology
Pathology
Materials science
Health care
Pharmaceutical Preparations
Toxicity
Proteins
Developed Countries
Degradation
Biological Availability
Molecules

Keywords

  • Alzheimer's disease
  • Hydrogels
  • Intranasal delivery
  • Nanocomposites
  • Nanoparticles
  • Nanotoxicity
  • Parkinson's disease

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Bioengineering
  • Medicine (miscellaneous)

Cite this

Nanocomposites for neurodegenerative diseases : Hydrogel-nanoparticle combinations for a challenging drug delivery. / Giordano, Carmen; Albani, Diego; Gloria, Antonio; Tunesi, Marta; Rodilossi, Serena; Russo, Teresa; Forloni, Gianluigi; Ambrosio, Luigi; Cigada, Alberto.

In: International Journal of Artificial Organs, Vol. 34, No. 12, 12.2011, p. 1115-1127.

Research output: Contribution to journalArticle

Giordano, Carmen ; Albani, Diego ; Gloria, Antonio ; Tunesi, Marta ; Rodilossi, Serena ; Russo, Teresa ; Forloni, Gianluigi ; Ambrosio, Luigi ; Cigada, Alberto. / Nanocomposites for neurodegenerative diseases : Hydrogel-nanoparticle combinations for a challenging drug delivery. In: International Journal of Artificial Organs. 2011 ; Vol. 34, No. 12. pp. 1115-1127.
@article{5a5a9a0fe34d444d9bb4c75fe3311a9c,
title = "Nanocomposites for neurodegenerative diseases: Hydrogel-nanoparticle combinations for a challenging drug delivery",
abstract = "Neurodegenerative disorders are expected to strike social and health care systems of developed countries heavily in the coming decades. Alzheimer's and Parkinson's diseases (AD/PD) are the most prevalent neurodegenerative pathologies, and currently their available therapy is only symptomatic. However, innovative potential drugs are actively under development, though their efficacy is sometimes limited by poor brain bioavailability and/or sustained peripheral degradation. To partly overcome these constraints, the development of drug delivery devices made by biocompatible and easily administrable materials might be a great adjuvant. In particular, materials science can provide a powerful tool to design hydrogels and nanoparticles as basic components of more complex nanocomposites that might ameliorate drug or cell delivery in AD/PD. This kind of approach is particularly promising for intranasal delivery, which might increase brain targeting of neuroprotective molecules or proteins. Here we review these issues, with a focus on nanoparticles as nanocomponents able to carry and tune drug release in the central nervous system, without ignoring warnings concerning their potential toxicity.",
keywords = "Alzheimer's disease, Hydrogels, Intranasal delivery, Nanocomposites, Nanoparticles, Nanotoxicity, Parkinson's disease",
author = "Carmen Giordano and Diego Albani and Antonio Gloria and Marta Tunesi and Serena Rodilossi and Teresa Russo and Gianluigi Forloni and Luigi Ambrosio and Alberto Cigada",
year = "2011",
month = "12",
doi = "10.5301/ijao.2011.8915",
language = "English",
volume = "34",
pages = "1115--1127",
journal = "International Journal of Artificial Organs",
issn = "0391-3988",
publisher = "Wichtig Publishing",
number = "12",

}

TY - JOUR

T1 - Nanocomposites for neurodegenerative diseases

T2 - Hydrogel-nanoparticle combinations for a challenging drug delivery

AU - Giordano, Carmen

AU - Albani, Diego

AU - Gloria, Antonio

AU - Tunesi, Marta

AU - Rodilossi, Serena

AU - Russo, Teresa

AU - Forloni, Gianluigi

AU - Ambrosio, Luigi

AU - Cigada, Alberto

PY - 2011/12

Y1 - 2011/12

N2 - Neurodegenerative disorders are expected to strike social and health care systems of developed countries heavily in the coming decades. Alzheimer's and Parkinson's diseases (AD/PD) are the most prevalent neurodegenerative pathologies, and currently their available therapy is only symptomatic. However, innovative potential drugs are actively under development, though their efficacy is sometimes limited by poor brain bioavailability and/or sustained peripheral degradation. To partly overcome these constraints, the development of drug delivery devices made by biocompatible and easily administrable materials might be a great adjuvant. In particular, materials science can provide a powerful tool to design hydrogels and nanoparticles as basic components of more complex nanocomposites that might ameliorate drug or cell delivery in AD/PD. This kind of approach is particularly promising for intranasal delivery, which might increase brain targeting of neuroprotective molecules or proteins. Here we review these issues, with a focus on nanoparticles as nanocomponents able to carry and tune drug release in the central nervous system, without ignoring warnings concerning their potential toxicity.

AB - Neurodegenerative disorders are expected to strike social and health care systems of developed countries heavily in the coming decades. Alzheimer's and Parkinson's diseases (AD/PD) are the most prevalent neurodegenerative pathologies, and currently their available therapy is only symptomatic. However, innovative potential drugs are actively under development, though their efficacy is sometimes limited by poor brain bioavailability and/or sustained peripheral degradation. To partly overcome these constraints, the development of drug delivery devices made by biocompatible and easily administrable materials might be a great adjuvant. In particular, materials science can provide a powerful tool to design hydrogels and nanoparticles as basic components of more complex nanocomposites that might ameliorate drug or cell delivery in AD/PD. This kind of approach is particularly promising for intranasal delivery, which might increase brain targeting of neuroprotective molecules or proteins. Here we review these issues, with a focus on nanoparticles as nanocomponents able to carry and tune drug release in the central nervous system, without ignoring warnings concerning their potential toxicity.

KW - Alzheimer's disease

KW - Hydrogels

KW - Intranasal delivery

KW - Nanocomposites

KW - Nanoparticles

KW - Nanotoxicity

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84455195432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84455195432&partnerID=8YFLogxK

U2 - 10.5301/ijao.2011.8915

DO - 10.5301/ijao.2011.8915

M3 - Article

C2 - 22198597

AN - SCOPUS:84455195432

VL - 34

SP - 1115

EP - 1127

JO - International Journal of Artificial Organs

JF - International Journal of Artificial Organs

SN - 0391-3988

IS - 12

ER -